FINANCIAL INSTRUMENTS (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
| Derivative Instruments and Hedging Activities Disclosure [Abstract] |
|
| Schedule of Foreign Exchange Derivative Contracts Outstanding |
At March 31, 2026, the following notional amounts related to foreign currency derivative contracts were outstanding, which mature through March 2028: | | | | | | | | | | | | | | | | (in millions) | | Notional Amount* | | Traded Currency | | Notional in Traded Currency | | Notional in Approximate U.S. Dollar | | | | | | | U.S. Dollar | | 714 | | | $ | 714 | | | | | | | | | | | | | Mexican Peso | | 3,680 | | | $ | 203 | | | | | | | | Polish Zloty | | 585 | | | $ | 157 | | | Euro | | 117 | | | $ | 135 | | | | | | | | | | | | | Hungarian Forint | | 14,014 | | | $ | 41 | | | | | | | | British Pound | | 30 | | | $ | 40 | | | Swiss Franc | | 25 | | | $ | 31 | | | | | | | | | | | | | | | | | | | | | | *Table above excludes non-significant traded currency with total notional amounts of less than $10 million U.S. Dollar equivalent as of March 31, 2026. |
|
| Schedule of Foreign Exchange Contracts, Statement of Financial Position |
At March 31, 2026 and December 31, 2025, the following cross-currency swap contracts were outstanding and mature through August 2030: | | | | | | | | | | | | | Cross-currency swaps | | (in millions) | March 31, 2026 | | December 31, 2025 | | U.S. Dollar to Euro: | | | | | Fixed receiving notional | $ | 1,450 | | | $ | 1,600 | | | Fixed paying notional | € | 1,321 | | | € | 1,454 | | | U.S. Dollar to Chinese Renminbi: | | | | | Fixed receiving notional | $ | 100 | | | $ | — | | | Fixed paying notional | ¥ | 676 | | | ¥ | — | | | U.S. Dollar to Japanese Yen: | | | | | Fixed receiving notional | $ | 150 | | | $ | 100 | | | Fixed paying notional | ¥ | 20,663 | | | ¥ | 12,724 | |
|
| Schedule of Derivatives Instruments in Statements of Financial Position |
At March 31, 2026 and December 31, 2025, the following amounts were recorded in the Condensed Consolidated Balance Sheets as being payable to or receivable from counterparties for derivative instruments under ASC Topic 815, “Derivatives and Hedging”: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Assets | | Liabilities | | Derivatives designated as hedging instruments Under 815: | | Location | | March 31, 2026 | | December 31, 2025 | | Location | | March 31, 2026 | | December 31, 2025 | | Foreign currency | | Prepayments and other current assets | | $ | 20 | | | $ | 18 | | | Other current liabilities | | $ | 11 | | | $ | 16 | | | Foreign currency | | Other non-current assets | | $ | 4 | | | $ | 4 | | | Other non-current liabilities | | $ | 2 | | | $ | 3 | | | | | | | | | | | | | | | | Net investment hedges | | Other non-current assets | | $ | 23 | | | $ | 23 | | | Other non-current liabilities | | $ | 57 | | | $ | 94 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Derivatives not designated as hedging instruments: | | | | | | | | | | | | | | Foreign currency | | Prepayments and other current assets | | $ | — | | | $ | — | | | Other current liabilities | | $ | — | | | $ | — | | | | | | | | | | | | | | |
|
| Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) |
The table below shows deferred gain (loss) reported in AOCI as well as the amount expected to be reclassified to income in one year or less for designated hedges. The amount expected to be reclassified to income in one year or less assumes no change in the current relationship of the hedged item at March 31, 2026 market rates. | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Deferred gain (loss) in AOCI at | | Gain (loss) expected to be reclassified to income in one year or less | | Contract Type | | March 31, 2026 | | December 31, 2025 | | | Cash flow hedges: | | | | | | | | Foreign currency | | $ | 11 | | | $ | 7 | | | $ | 8 | | | Net investment hedges: | | | | | | | | | | | | | | | Cross-currency swaps | | $ | (38) | | | $ | (71) | | | $ | — | | | Foreign currency-denominated debt | | 48 | | | 29 | | | — | | | Total | | $ | 21 | | | $ | (35) | | | $ | 8 | |
|
| Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) |
The table below shows deferred gain (loss) reported in AOCI as well as the amount expected to be reclassified to income in one year or less for designated hedges. The amount expected to be reclassified to income in one year or less assumes no change in the current relationship of the hedged item at March 31, 2026 market rates. | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Deferred gain (loss) in AOCI at | | Gain (loss) expected to be reclassified to income in one year or less | | Contract Type | | March 31, 2026 | | December 31, 2025 | | | Cash flow hedges: | | | | | | | | Foreign currency | | $ | 11 | | | $ | 7 | | | $ | 8 | | | Net investment hedges: | | | | | | | | | | | | | | | Cross-currency swaps | | $ | (38) | | | $ | (71) | | | $ | — | | | Foreign currency-denominated debt | | 48 | | | 29 | | | — | | | Total | | $ | 21 | | | $ | (35) | | | $ | 8 | |
Gains and losses on derivative instruments designated as net investment hedges were recognized in other comprehensive income (loss) during the periods presented below.
| | | | | | | | | | | | | | | | | | | | (in millions) | | Three Months Ended March 31, | | | | Net investment hedges | | 2026 | | 2025 | | | | | | | | | | | | | | | Cross-currency swaps | | $ | 33 | | | $ | (49) | | | | | | | Foreign currency-denominated debt | | $ | 19 | | | $ | (46) | | | | | |
|
| Schedule of Derivative Instruments |
Derivative instruments designated as hedging instruments as defined by ASC Topic 815 held during the period resulted in the gains and losses recorded in income shown in the table below. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2026 | | (in millions) | | Net sales | | Cost of sales | | Selling, general and administrative expenses | | Other comprehensive income (loss) | | Total amounts of earnings and other comprehensive income (loss) line items in which the effects of cash flow hedges are recorded | | $ | 3,533 | | | $ | 2,856 | | | $ | 328 | | | $ | — | | | Gain (loss) on cash flow hedging relationships: | | | | | | | | | | Foreign currency: | | | | | | | | | | Gain (loss) recognized in other comprehensive income | | | | | | | | $ | 8 | | | Gain (loss) reclassified from AOCI to income | | $ | — | | | $ | 3 | | | $ | — | | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2025 | | (in millions) | | Net sales | | Cost of sales | | Selling, general and administrative expenses | | Other comprehensive income (loss) | | Total amounts of earnings and other comprehensive income (loss) line items in which the effects of cash flow hedges are recorded | | $ | 3,515 | | | $ | 2,876 | | | $ | 315 | | | $ | 59 | | | Gain (loss) on cash flow hedging relationships: | | | | | | | | | | Foreign currency: | | | | | | | | | | Gain (loss) recognized in other comprehensive income | | | | | | | | $ | (1) | | | Gain (loss) reclassified from AOCI to income | | $ | — | | | $ | (2) | | | $ | (2) | | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Schedule of Derivative Instruments, Gain (Loss) |
Derivatives designated as net investment hedge instruments, as defined by ASC Topic 815, held during the period resulted in the following gains recorded in Interest expense on components excluded from the assessment of effectiveness: | | | | | | | | | | | | | | | | | | | | (in millions) | | Three Months Ended March 31, | | | | Net investment hedges | | 2026 | | 2025 | | | | | | Cross-currency swaps | | $ | 6 | | | $ | 6 | | | | | |
|
| Schedule of Derivatives Not Designated as Hedging Instruments |
Derivatives not designated as hedging instruments are used to hedge remeasurement exposures of monetary assets and liabilities denominated in currencies other than the operating units’ functional currency. These derivatives resulted in gains (losses) recorded in income as shown in the table below. | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | | | Three Months Ended March 31, | | | | Contract Type | | Location | | 2026 | | 2025 | | | | | | Foreign currency | | Selling, general and administrative expenses | | $ | 2 | | | $ | — | | | | | |
|